Implantable Glucose Sensor with Prolonged Accuracy

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DK074243-01
Agency Tracking Number: DK074243
Amount: $145,049.00
Phase: Phase I
Program: SBIR
Awards Year: 2006
Solicitation Year: 2006
Solicitation Topic Code: N/A
Solicitation Number: PHS2006-2
Small Business Information
MC3, INC.
MC3, INC., 3550 W LIBERTY RD, ANN ARBOR, MI, 48103
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MELISSA REYNOLDS
 (734) 995-9089
 REYNOLDS@MC3CORP.COM
Business Contact
 SEAN CHAMBERS
Phone: (734) 995-9089
Email: schambers@mc3corp.com
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The goal in this study is to fabricate an intravascular glucose sensor that functions accurately for 3 days in vivo. To do this, we will develop an outer membrane that facilitates the conversion of endogenous S- nitrosothiols to nitric oxide locally at the membrane/blood interface. Since nitric oxide is released by the endothelial cells and is responsible for maintaining vascular tone and platelet inactivation, this is a natural approach that mimics the functions of the endothelium. This study involves the design of a biocompatible glucose-selective membrane, fabrication of a functional glucose sensor, and bench and animal testing to assess biocompatibility and function of the sensor. Continuous monitoring of blood glucose levels has been an elusive goal, but would greatly improve the care for critically ill patients in managing insulin therapy.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government